D. E. Shaw & Co., Inc. Eq Rx, Inc. Transaction History

D. E. Shaw & Co., Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.66 - $2.31 $267,791 - $372,649	161,320 New	161,320 $358,000
Q2 2022 Aug 15, 2022	BUY	$3.2 - $5.69 $1.64 Million - $2.92 Million	513,406 Added 41.41%	1,753,311 $8.22 Million
Q1 2022 May 16, 2022	SELL	$2.8 - $7.39 $28,266 - $74,602	-10,095 Reduced 0.81%	1,239,905 $5.12 Million
Q4 2021 Feb 14, 2022	BUY	$5.92 - $9.98 $7.4 Million - $12.5 Million	1,250,000 New	1,250,000 $8.53 Million

67.8M

Ticker EQRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 448,140,992
Description
EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States. The company's pre-registrational programs in Phase III clinical trial include Aumolertinib, an epidermal growth factor receptor (EGFR) inhibitor for the treatment of patients with EG...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.